SCHEMBL5973771

SCHEMBL5973771

Cc1cc(Cl)cc2[nH]c(=O)c(=O)[nH]c12

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GRIN1 Q05586 19/20 0.68
▸ GRIN2D O15399 18/20 0.68
▸ GRIN3B O60391 18/20 0.68
▸ GRIN2A Q12879 18/20 0.68
▸ GRIN2B Q13224 18/20 0.68
▸ GRIN2C Q14957 18/20 0.68
▸ GRIN3A Q8TCU5 18/20 0.68
▸ HSD17B10 Q99714 3/20 0.68
▸ KDM4E B2RXH2 2/20 0.68
▸ ALDH1A1 P00352 2/20 0.68
▸ GAA P10253 1/20 0.68
▸ MEN1 O00255 1/20 0.46
▸ LMNA P02545 1/20 0.46
▸ CYP1A2 P05177 1/20 0.46
▸ MAPT P10636 1/20 0.46
▸ HPGD P15428 1/20 0.46
▸ TSHR P16473 1/20 0.46
▸ THPO P40225 1/20 0.46
▸ GRIA1 P42261 1/20 0.46
▸ GRIA2 P42262 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2639494 0.81 GRIN2D (1.00) GRIN1GRIN2DGRIN3BGRIN2AGRIN2B
SCHEMBL7784329 0.78 GRIN2D (1.00) GRIN1GRIN2DGRIN3BGRIN2AGRIN2B
SCHEMBL4704849 0.78 GRIN1 (0.66) GRIN1GRIN2DGRIN3BGRIN2AGRIN2B
SCHEMBL463620 0.78 GRIN1 (0.66) GRIN1GRIN2DGRIN3BGRIN2AGRIN2B
SCHEMBL5973354 0.77 GRIN1 (0.67) GRIN1GRIN2DGRIN3BGRIN2AGRIN2B
SCHEMBL5973665 0.75 GRIN1 (0.64) GRIN1GRIN2DGRIN3BGRIN2AGRIN2B
SCHEMBL8872169 0.73 GRIN2D (0.85) GRIN1GRIN2DGRIN3BGRIN2AGRIN2B
SCHEMBL4707291 0.73 GRIN1 (0.59) GRIN1GRIN2DGRIN3BGRIN2AGRIN2B
Phosphonic Acid SCHEMBL27504235 0.72 GRIN1 (0.60) GRIN1GRIN2DGRIN3BGRIN2AGRIN2B
SCHEMBL7345843 0.72 GRIN2D (1.00) GRIN1GRIN2DGRIN3BGRIN2AGRIN2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0934326-B1 SUBSTITUTED AMINOALKANE PHOSPHONIC ACIDS NOVARTIS AG (CH) 2006-05-03 — — EP disclosed
US-6117873-A CAN BE USED FOR THE TREATMENT OF PATHOLOGICAL CONDITIONS WHICH RESPOND TO BLOCKAGE OF EXCITATORY AMINO ACID RECEPTORS NOVARTIS AG (CH) 2000-09-12 — — US disclosed
EP-0934326-A1 SUBSTITUTED AMINOALKANE PHOSPHONIC ACIDS Novartis AG (CH) 1999-08-11 — — EP disclosed
WO-1998017672-A1 SUBSTITUTED AMINOALKANE PHOSPHONIC ACIDS NOVARTIS AG (CH) 1998-04-30 — — WO disclosed
Send feedback